Toll-like receptor (TLR) signaling must be tightly regulated to avoid uncontrolled inflammation. A fifth Toll–interleukin 1 receptor adaptor domain, SARM, has been identified as an inhibitor of TLR3 and TLR4 signaling.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Liew, F.Y., Xu, D., Brint, E.K. & O'Neill, L.A.J. Nat. Rev. Immunol. 5, 446–458 (2005).
Carty, M. et al. Nat. Immunol. 7, 1074–1081 (2006).
Mink, M., Fogelgren, B., Olszewski, K., Maroy, P. & Csiszar, K. Genomics 74, 234–244 (2001).
O'Neill, L.A.J., Fitzgerald, K.A. & Bowie, A.G. Trends Immunol. 24, 286–289 (2003).
Fitzgerald, K.A. et al. J. Exp. Med. 198, 1043–1055 (2003).
Fitzgerald, K.A. et al. Nature 413, 78–83 (2001).
Couillault, C. et al. Nat. Immunol. 5, 488–494 (2004).
Liberati, N.T. et al. Proc. Natl. Acad. Sci. USA 101, 6593–6598 (2004).
Chuang, C.F. & Bargmann, C.I. Genes Dev. 19, 270–281 (2005).
Kim, C.A. & Bowie, J.U. Trends Biochem. Sci. 28, 625–628 (2003).
Su, X. et al. Eur. J. Immunol. 36, 199–206 (2006).
Rowe, D. et al. Proc. Natl. Acad. Sci. USA 103, 6299–6304 (2006).
McGettrick, A. et al. Proc. Natl. Acad. Sci. USA 103, 9196–9201 (2006).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
O'Neill, L. DisSARMing Toll-like receptor signaling. Nat Immunol 7, 1023–1025 (2006). https://doi.org/10.1038/ni1006-1023
Issue Date:
DOI: https://doi.org/10.1038/ni1006-1023
This article is cited by
-
TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity
Nature Medicine (2007)
-
The negative regulation of Toll‐like receptor and associated pathways
Immunology & Cell Biology (2007)